The Trump administration moved swiftly in the past 24 hours to implement pieces of its plan to bring down drug prices.
bring down drug prices curb kickback exemptions biosimilars Related: Insurers to Trump: Let our drug price negotiators work hammering Pfizer Novartis AG © 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
By Alan Goforth | May 12, 2025
A group of investors last week filed a proposed class-action lawsuit against UnitedHealth Group, alleging that the company withheld information following the murder of UnitedHealthcare CEO Brian Thompson last December.
By Allison Bell | May 12, 2025
About 11 million workers who have chronic kidney disease now account for $105 billion in annual employer plan spending.
By Allison Bell | May 12, 2025
Health and Human Services Secretary Robert F. Kennedy Jr. is in charge of helping patients buy drugs at "most-favored-nation" prices.
Report
Sponsored by New Benefits
Employer Trends Across the Benefits Landscape: An HR Pulse Survey
Rising costs & low engagement challenge employers. This HR Pulse Survey reveals key trends from HR leaders across various industries and looks at the opportunities for brokers to elevate service, address pain points, and demonstrate ROI, especially with non-insured benefits.
Guide
Sponsored by New Benefits
Identifying Benefits Blind Spots: 3 Steps to Building a Well-Rounded Benefits Playbook
Clients expect strategic advice, not just sales. This guide reveals 3 steps to audit benefits, fill gaps, and present holistic strategies that meet client goals and employee needs--positioning employee benefits brokers as trusted advisors.
Guide
Sponsored by ArmadaCare
Benefit Strategy Savers: A Broker's Guide to Solving 2025 Benefit Challenges
Discover how employer-paid supplemental health benefits can help close coverage gaps, reduce out-of-pocket costs, and boost retention!
